Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1998-1-29
pubmed:abstractText
We have developed a new recombinant retroviral system in which a library of infectious molecular clones of human immunodeficiency virus type 1 (HIV-1) is constructed with reverse transcriptase (RT) genes derived from viral RNA sequences in plasma. HIV-1 RT is amplified from plasma HIV-1 RNA by nested RT-PCR and cloned into a RT-defective HIV-1 proviral vector (xxLAI-np), generating 10(3) to 10(4) recombinant proviral clones from each reaction. The bulk cloning products or individual molecular clones are transfected into MT-2 cells to generate infectious virus. The resultant viruses are assayed for drug susceptibility in CD4+ cell lines to determine either the dominant phenotype of the recombinant virus mixture or the phenotypes of the individual viral clones. DNA sequencing of the cloned RT genes can identify mutations associated with phenotypic resistance of clonal mixtures or individual clones. This method can be used to rapidly detect the in vivo emergence of HIV-1 quasispecies resistant to RT inhibitors.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-1375948, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-1381438, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-1383414, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-1683726, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-1707532, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-1709563, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-1720152, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-1731112, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-1955709, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-2002543, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-2034672, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-2186361, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-7508227, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-7529334, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-7840579, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-8141575, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-8517697, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-8573378, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-8709214, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-8891152, http://linkedlifedata.com/resource/pubmed/commentcorrection/9420060-8892925
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2781-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
A recombinant retroviral system for rapid in vivo analysis of human immunodeficiency virus type 1 susceptibility to reverse transcriptase inhibitors.
pubmed:affiliation
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania 15261, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.